Angela Celetti

Via Pansini, 5
Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasion.

KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasion.

Journal: Apoptosis : an international journal on programmed cell death

Published: May 18, 2026

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.

Journal: Cancer research communications

Published: August 04, 2025

Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents.

Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents.

Journal: Neoplasia (New York, N.Y.)

Published: October 14, 2024

A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options.

A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options.

Journal: Exploration of targeted anti-tumor therapy

Published: May 13, 2022

The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.

The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 04, 2022

Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.

Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.

Journal: Cancer letters

Published: July 28, 2021

The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis.

The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis.

Journal: Heliyon

Published: July 12, 2021

Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress.

Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress.

Journal: Cancers

Published: July 07, 2021

Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.

Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.

Journal: Oral oncology

Published: March 18, 2021

Retraction Note: Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors.

Retraction Note: Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors.

Journal: BMC cancer

Published: January 28, 2021

Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives.

Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives.

Journal: Cells

Published: November 20, 2020

Erratum: Epigenetics of oral and oropharyngeal cancers (Review).

Erratum: Epigenetics of oral and oropharyngeal cancers (Review).

Journal: Biomedical reports

Published: April 08, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026